A detailed history of Clear Street Markets LLC transactions in Biogen Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 800 shares of BIIB stock, worth $180,520. This represents 0.03% of its overall portfolio holdings.

Number of Shares
800
Previous 912 12.28%
Holding current value
$180,520
Previous $236,000 26.69%
% of portfolio
0.03%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $23,746 - $29,983
-112 Reduced 12.28%
800 $173,000
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $199,440 - $240,074
896 Added 5600.0%
912 $236,000
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $8,105 - $9,148
-32 Reduced 66.67%
16 $4,000
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $13,212 - $15,266
48 New
48 $14,000
Q3 2022

Nov 02, 2022

BUY
$194.69 - $268.46 $111,167 - $153,290
571 New
571 $152,000
Q1 2022

May 11, 2022

BUY
$193.77 - $244.14 $128,663 - $162,108
664 New
664 $140,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.